Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Surface Oncology, Inc. (SURF)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
1 Aug 2023
Adams Chandra
Deputy GC, Officer
Surface Oncology, Inc.
(SURF)
30,899
-11%
3,901
$0.94
$3,666.94
SELL
1 Aug 2023
FEES JESSICA
Chief Financial Officer, Officer
Surface Oncology, Inc.
(SURF)
101,915
-8%
9,434
$0.94
$8,867.96
SELL
1 Aug 2023
ONEILL ALISON
Chief Medical Officer, Officer
Surface Oncology, Inc.
(SURF)
56,686
-11%
7,042
$0.94
$6,619.48
SELL
1 Aug 2023
ROSS ROBERT W.
Chief Executive Officer, Officer
Surface Oncology, Inc.
(SURF)
83,193
-16%
16,713
$0.94
$15,710.22
SELL
3 Aug 2022
RATH HENRY C.
Chief Business Officer, Officer
Surface Oncology, Inc.
(SURF)
32,324
-14%
5,676
$1.72
$9,762.72
SELL
3 Aug 2022
ONEILL ALISON
Chief Medical Officer, Officer
Surface Oncology, Inc.
(SURF)
63,728
-6%
4,463
$1.72
$7,676.36
SELL
3 Aug 2022
ROSS ROBERT W.
Chief Executive Officer, Officer
Surface Oncology, Inc.
(SURF)
99,906
-9%
10,594
$1.72
$18,221.68
SELL
3 Aug 2022
FEES JESSICA
Chief Financial Officer, Officer
Surface Oncology, Inc.
(SURF)
111,349
-5%
5,980
$1.72
$10,285.60
SELL
3 Aug 2022
Palombella Vito J.
Chief Scientific Officer, Officer
Surface Oncology, Inc.
(SURF)
87,212
-4%
4,463
$1.72
$7,676.36
SELL
21 Jul 2021
Nogelo Liisa I
Chief Legal Officer, Officer
Surface Oncology, Inc.
(SURF)
53,675
-32%
26,325
$6.10
$160,582.50
SELL
21 Jul 2021
Goater Jeff
Director
Surface Oncology, Inc.
(SURF)
129,222
-49%
127,778
$6.10
$779,445.80
SELL
21 Jul 2021
FEES JESSICA
Chief Financial Officer, Officer
Surface Oncology, Inc.
(SURF)
79,329
-20%
19,854
$6.10
$121,109.40
SELL
21 Jul 2021
Palombella Vito J.
Chief Scientific Officer, Officer
Surface Oncology, Inc.
(SURF)
53,675
-32%
26,325
$6.10
$160,582.50
SELL
21 Jul 2021
ROSS ROBERT W.
Chief Executive Officer, Officer
Surface Oncology, Inc.
(SURF)
54,500
-38%
33,500
$6.10
$204,350.00
SELL
10 Jun 2021
Goater Jeff
Director
Surface Oncology, Inc.
(SURF)
257,000
-49%
250,000
$7.66
$1,914,845.10
SELL
16 Feb 2021
ROSS ROBERT W.
Chief Medical Officer, Officer
Surface Oncology, Inc.
(SURF)
88,000
-1%
1,000
$11.35
$11,350.00
SELL
8 Feb 2021
FEES JESSICA
See Remarks, Officer
Surface Oncology, Inc.
(SURF)
99,183
-1%
1,500
$12.45
$18,675.00
SELL
8 Feb 2021
Goater Jeff
Chief Executive Officer, Director, Officer
Surface Oncology, Inc.
(SURF)
262,000
-0%
2,500
$12.50
$31,250.00
SELL
1 Feb 2021
Goater Jeff
Chief Executive Officer, Director, Officer
Surface Oncology, Inc.
(SURF)
262,000
-0%
2,500
$10.69
$26,717.50
SELL
1 Feb 2021
FEES JESSICA
See Remarks, Officer
Surface Oncology, Inc.
(SURF)
100,683
-1%
1,500
$11.19
$16,785.00
SELL
19 Jan 2021
Goater Jeff
Chief Executive Officer, Director, Officer
Surface Oncology, Inc.
(SURF)
262,000
-1%
5,000
$13.00
$65,000.00
SELL
14 Jan 2021
ROSS ROBERT W.
Chief Medical Officer, Officer
Surface Oncology, Inc.
(SURF)
89,000
-9%
9,000
$12.02
$108,150.00
SELL
17 Dec 2020
GRAYZEL DAVID S.
Director
Surface Oncology, Inc.
(SURF)
2,945,453
-36%
1,700,000
$18.10
$30,770,000.00
SELL
17 Dec 2020
Atlas Venture Fund IX, L.P.
10% Owner
Surface Oncology, Inc.
(SURF)
2,945,453
-36%
1,700,000
$18.10
$30,770,000.00
SELL
15 Dec 2020
ROSS ROBERT W.
Chief Medical Officer, Officer
Surface Oncology, Inc.
(SURF)
98,000
-1%
1,000
$10.48
$10,480.00
SELL
11 Dec 2020
ROSS ROBERT W.
Chief Medical Officer, Officer
Surface Oncology, Inc.
(SURF)
99,000
-1%
1,405
$10.05
$14,120.25
SELL
11 Nov 2020
ROSS ROBERT W.
Chief Medical Officer, Officer
Surface Oncology, Inc.
(SURF)
100,405
-0%
595
$10.05
$5,979.75
SELL
14 Oct 2020
ROSS ROBERT W.
Chief Medical Officer, Officer
Surface Oncology, Inc.
(SURF)
101,000
-3%
4,000
$10.05
$40,200.00
SELL
1 Sep 2020
EcoR1 Capital, LLC
10% Owner
Surface Oncology, Inc.
(SURF)
4,701,081
-6%
332,780
$7.14
$2,376,681.50
SELL
20 May 2020
New Enterprise Associates 14, L.P.
10% Owner
Surface Oncology, Inc.
(SURF)
2,892,877
-12%
420,000
$3.66
$1,535,562.00
SELL
1 Mar 2020
ONEILL ALISON
Chief Medical Officer, Officer
Surface Oncology, Inc.
(SURF)
30,191
-32%
14,809
$6.10
$90,334.90
BUY
5 Feb 2020
Goater Jeff
Chief Executive Officer, Director, Officer
Surface Oncology, Inc.
(SURF)
262,000
+1%
5,000
$3.23
$16,150.00
BUY
23 Apr 2018
Sonsini Peter W.
10% Owner
Surface Oncology, Inc.
(SURF)
3,312,877
+4%
133,333
$15.00
$1,999,995.00
BUY
23 Apr 2018
GRAYZEL DAVID S.
Director
Surface Oncology, Inc.
(SURF)
4,645,453
+2%
100,000
$15.00
$1,500,000.00
BUY
23 Apr 2018
LV Management Group, LLC
10% Owner
Surface Oncology, Inc.
(SURF)
3,447,817
+8%
266,000
$15.00
$3,990,000.00
BUY
23 Apr 2018
BARRIS PETER J
10% Owner
Surface Oncology, Inc.
(SURF)
3,312,877
+4%
133,333
$15.00
$1,999,995.00
BUY
23 Apr 2018
MOTT DAVID M
10% Owner
Surface Oncology, Inc.
(SURF)
3,312,877
+4%
133,333
$15.00
$1,999,995.00
BUY
23 Apr 2018
Viswanathan Ravi
10% Owner
Surface Oncology, Inc.
(SURF)
3,312,877
+4%
133,333
$15.00
$1,999,995.00
BUY
23 Apr 2018
SANDELL SCOTT D
10% Owner
Surface Oncology, Inc.
(SURF)
3,312,877
+4%
133,333
$15.00
$1,999,995.00
BUY
23 Apr 2018
KERINS PATRICK J
10% Owner
Surface Oncology, Inc.
(SURF)
3,312,877
+4%
133,333
$15.00
$1,999,995.00
BUY
23 Apr 2018
Florence Anthony A. Jr.
10% Owner
Surface Oncology, Inc.
(SURF)
3,312,877
+4%
133,333
$15.00
$1,999,995.00
BUY
23 Apr 2018
BASKETT FOREST
10% Owner
Surface Oncology, Inc.
(SURF)
3,312,877
+4%
133,333
$15.00
$1,999,995.00
BUY
23 Apr 2018
BARRETT M JAMES
10% Owner
Surface Oncology, Inc.
(SURF)
3,312,877
+4%
133,333
$15.00
$1,999,995.00
BUY
23 Apr 2018
New Enterprise Associates 14, L.P.
10% Owner
Surface Oncology, Inc.
(SURF)
3,312,877
+4%
133,333
$15.00
$1,999,995.00
BUY
23 Apr 2018
Novartis Institutes for BioMedical Research, Inc.
10% Owner
Surface Oncology, Inc.
(SURF)
3,948,482
+24%
766,666
$15.00
$11,499,990.00
BUY
23 Apr 2018
Atlas Venture Fund IX, L.P.
10% Owner
Surface Oncology, Inc.
(SURF)
4,645,453
+2%
100,000
$15.00
$1,500,000.00
BUY
23 Apr 2018
Shanafelt Armen
Director, 10% Owner
Surface Oncology, Inc.
(SURF)
3,447,817
+8%
266,000
$15.00
$3,990,000.00
Home